Suchergebnisse - (Person:"Wu, Jiajing")

PubPharm (19)

1

Rational prediction of immunogenicity clustering through cross-reactivity analysis of thirteen SARS-CoV-2 variants

enthalten in: Journal of medical virology | 2024

von Liang, Z. | Tong, J. | Sun, Z. | +11

2

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

enthalten in: Emerging microbes & infections | 2023

von Liang, Z. | Wu, X. | Wu, J. | +11

3

Pseudotyped Viruses

enthalten in: Advances in experimental medicine and biology | 2023

von Wang, Y. | Zhou, Z. | Wu, X. | +6

4

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination

enthalten in: Emerging microbes & infections | 2022

von Wang, M. | Zhang, L. | Li, Q. | +10

5

Analysis of SARS-CoV-2 variants B.1.617 : host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity

enthalten in: Emerging microbes & infections | 2022

von Zhang, L. | Li, Q. | Wu, J. | +19

6

Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift

enthalten in: Journal of medical virology | 2022

von Li, T. | Cui, Z. | Jia, Y. | +17

7

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

enthalten in: Nature | 2022

von Wang, K. | Jia, Z. | Bao, L. | +31

CommentIn: Signal Transduct Target Ther. 2022 Apr 5;7(1):115. - PMID 35383164

8

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain

enthalten in: Signal transduction and targeted therapy | 2022

von Wu, J. | Nie, J. | Zhang, L. | +16

9

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization

enthalten in: Communications biology | 2021

von Zhang, L. | Cui, Z. | Li, Q. | +14

10

Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19

enthalten in: Vaccine | 2021

von Zhou, Z. | Zhang, X. | Li, Q. | +14